Most lately, it's been discovered that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar parts as classical opioid receptors, it binds to some big range of endogenous opioids. Unlike most opioid receptors, this receptor acts as being a scavenger and does not activate a 2nd messen